Weekly recap

IPOs, SPACs and new listings: week of Oct 12–18, 2026

Week of Oct 12–18, 2026: 3 US IPOs priced raising $370M; 2 SPAC IPOs; 3 SPAC deals announced; 0 deSPACs closed; 3 new IPO filings. The largest IPO was City Therapeutics, Inc., raising $200M.

← Previous week All weeks

US IPOs priced3$370M raised

SPAC IPOs2$175M raised

SPAC deals announced3

deSPACs closed0

US IPOs, direct listings and uplistings

Company	Type	Priced	Price	Raised	Market cap	Lead-left
City Therapeutics, Inc.	IPO	Oct 16, 2026	$18.00	$200M	$931M	Goldman Sachs
Iambic Therapeutics, Inc.	IPO	Oct 15, 2026	$16.00	$150M	$758.4M	J.P. Morgan
Amaero Inc.	IPO	Oct 15, 2026	$4.25	$20M	$121.3M	Baird

New IPO filings

Company	First filed	Form	Exchange
Tattvance Corp	Oct 14, 2026	S-1	—
Cashlin	Oct 15, 2026	S-1	—
Talyxor Corp	Oct 16, 2026	S-1	—

SPAC IPOs

SPAC	Priced	Size	Lead underwriter
TCGX Acquisition Corp. II	Oct 16, 2026	$100M	—
Frazier Life Sciences Acquisition Corp. II	Oct 14, 2026	$75M	—

SPAC deals announced

SPAC	Target	Announced	Deal value
Pyrophyte Acquisition Corp. II	Sakuu Corporation	Oct 15, 2026	$600M
Horizon Space Acquisition I Corp.	ArcheNova Biotech Corp.	Oct 13, 2026	$2B
Quantumsphere Acquisition Corp	Fortune Favor Technology Inc.	Oct 13, 2026	$600M

SPAC mergers closed

None this week.

SPAC liquidations

SPAC	Date
SilverBox Corp IV	Oct 13, 2026

London listings

Company	Market	Admitted	Raised
Airtel Mobile Commerce N.V.	Main Market	Oct 14, 2026	£529.2M
Meantime Resources Plc	AIM	Oct 13, 2026	£15M

Reg A offerings qualified

Company	Tier	Qualified
GOA Therapeutics Corp	Tier2	Oct 13, 2026

Coming up

IPO calendar: deals expected to price this week and next · US IPO statistics · SPAC statistics